Excerpt: I respectfully request an update on the rulemaking for Section 23, including the anticipated date for issuance of the final regulations associated with Section 23. I share President Obama’s stated commitment to modernizing the nation’s regulatory process and removing unnecessary regulatory roadblocks.
Excerpt: We are writing to express grave concerns regarding a regulation … that would change longstanding policy regarding the 1984 Hatch-Waxman Act. The proposed regulation would allow generic manufacturers to alter an abbreviated new drug application (ANDA) label without the FDA’s prior approval.
Excerpt: "These actions raise questions not only about whether the Treasury Department’s new climate policies comport with its duties and functions, but also the practical impact on U.S. international humanitarian goals, trade policies, and foreign commerce."
Exceprt: Since the launch of HealthCare.gov on October I, the website has been plagued by a series of technical glitches and errors. Even as some progress has been made on basic front-end functionality two months after launch, questions remain about whether the information being transmitted from the Federally Facilitated Marketplace (FFM) to insurers is accurate.
Excerpt: "Despite DOE officials' repeated commitments to this committee that DOE will follow the law, the impartial U.S. Court of Appeals' conclusions indicate otherwise."
To read the letter, click here.
Excerpt: Given the widespread calls for the commission to respect the First Amendment and stay out of the editorial decisions of reporters and broadcasters, we were shocked to see that the FCC is putting itself back in the business of attempting to control the political speech of journalists.